Labcorp Holdings Biopharma Laboratory Services — Supplies Expense increased by 3.8% to $121.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.4%, from $111.10M to $121.50M. Over 3 years (FY 2022 to FY 2025), Biopharma Laboratory Services — Supplies Expense shows relatively stable performance with a 1.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in supplies expense relative to revenue may signal rising material costs or lower operational efficiency in testing.
This represents the costs of materials, reagents, and other consumables required to perform laboratory tests and service...
Common variable cost metric for clinical and diagnostic laboratory businesses.
lh_segment_biopharma_laboratory_services_supplies_expense| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $115.15M | $115.15M | $115.15M | $115.15M | $113.05M | $113.05M | $113.05M | $113.05M | $103.50M | $106.70M | $109.50M | $122.20M | $111.10M | $130.80M | $119.50M | $117.10M | $121.50M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -1.8% | +0.0% | +0.0% | +0.0% | -8.4% | +3.1% | +2.6% | +11.6% | -9.1% | +17.7% | -8.6% | -2.0% | +3.8% |
| YoY Change | — | — | — | — | -1.8% | -1.8% | -1.8% | -1.8% | -8.4% | -5.6% | -3.1% | +8.1% | +7.3% | +22.6% | +9.1% | -4.2% | +9.4% |